Literature DB >> 9764035

Treatment of Helicobacter pylori infection: management of patients with ulcer disease by general practitioners and gastroenterologists.

G N Tytgat1.   

Abstract

Knowledge of the importance of Helicobacter pylori infection is still fragmentary. Currently only a minority of patients with ulcers receive adequate eradication therapy. Ideally there should be no difference in the level of knowledge between general practitioners and gastroenterologists. Yet in practice there is a substantial difference. The results obtained in highly selected clinical trials do not reflect results of practice in the real world. The gap can only be narrowed through careful mass education. The role of testing for H pylori infection in primary care practice needs to be clarified and the problem of erratic treatment by general practitioners and specialists needs to be resolved. Adequate response to these problems will require the creation of "regional platforms" where both primary care physicians and specialists decide on empirical therapy, eradication strategy and referral of dyspeptic patients.

Entities:  

Mesh:

Year:  1998        PMID: 9764035      PMCID: PMC1766598          DOI: 10.1136/gut.43.2008.s24

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Authors:  R W Van der Hulst; E A Rauws; B Köycü; J J Keller; M J Bruno; J G Tijssen; G N Tytgat
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Helicobacter pylori reinfection is virtually absent after successful eradication.

Authors:  R W van der Hulst; E A Rauws; B Köycü; J J Keller; F J ten Kate; J Dankert; G N Tytgat; A van der Ende
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Nonulcer dyspepsia: great expectations?

Authors:  R Jones
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

4.  Cost effectiveness of alternative Helicobacter pylori eradication strategies in the management of duodenal ulcer.

Authors:  B O'Brien; R Goeree; R Hunt; J Wilkinson; M Levine; A William
Journal:  Can J Gastroenterol       Date:  1997 May-Jun       Impact factor: 3.522

Review 5.  Diagnosing dyspepsia: any controversies left?

Authors:  P Bytzer
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

6.  Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease.

Authors:  A M Fendrick; R A Hirth; M E Chernew
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

7.  Alternative management strategies for patients with suspected peptic ulcer disease.

Authors:  A M Fendrick; M E Chernew; R A Hirth; B S Bloom
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

8.  Costs of duodenal ulcer therapy with antibiotics.

Authors:  A Sonnenberg; W F Townsend
Journal:  Arch Intern Med       Date:  1995-05-08

9.  Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.

Authors:  N Vakil; M B Fennerty
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

10.  Eradication of Helicobacter pylori in general practice.

Authors:  J G Penston; K R Mistry
Journal:  Aliment Pharmacol Ther       Date:  1996-04       Impact factor: 8.171

View more
  2 in total

1.  Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.

Authors:  Kyland P Holmes; John C Fang; Brian R Jackson
Journal:  BMC Health Serv Res       Date:  2010-12-21       Impact factor: 2.655

2.  Trends in hospitalizations for peptic ulcer disease, United States, 1998-2005.

Authors:  Lydia B Feinstein; Robert C Holman; Krista L Yorita Christensen; Claudia A Steiner; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.